These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10823817)

  • 1. Arrestin binding to the G protein-coupled N-formyl peptide receptor is regulated by the conserved "DRY" sequence.
    Bennett TA; Maestas DC; Prossnitz ER
    J Biol Chem; 2000 Aug; 275(32):24590-4. PubMed ID: 10823817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Internalization of the human N-formyl peptide and C5a chemoattractant receptors occurs via clathrin-independent mechanisms.
    Gilbert TL; Bennett TA; Maestas DC; Cimino DF; Prossnitz ER
    Biochemistry; 2001 Mar; 40(12):3467-75. PubMed ID: 11297412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of putative sites of interaction between the human formyl peptide receptor and G protein.
    Miettinen HM; Gripentrog JM; Mason MM; Jesaitis AJ
    J Biol Chem; 1999 Sep; 274(39):27934-42. PubMed ID: 10488141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of N-formyl peptide-mediated degranulation by receptor phosphorylation.
    Vines CM; Xue M; Maestas DC; Cimino DF; Prossnitz ER
    J Immunol; 2002 Dec; 169(12):6760-6. PubMed ID: 12471107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial phosphorylation of the N-formyl peptide receptor inhibits G protein association independent of arrestin binding.
    Bennett TA; Foutz TD; Gurevich VV; Sklar LA; Prossnitz ER
    J Biol Chem; 2001 Dec; 276(52):49195-203. PubMed ID: 11602585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of formyl peptide receptor agonist affinity by reconstitution with arrestins and heterotrimeric G proteins.
    Key TA; Bennett TA; Foutz TD; Gurevich VV; Sklar LA; Prossnitz ER
    J Biol Chem; 2001 Dec; 276(52):49204-12. PubMed ID: 11598142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple activation steps of the N-formyl peptide receptor.
    Prossnitz ER; Gilbert TL; Chiang S; Campbell JJ; Qin S; Newman W; Sklar LA; Ye RD
    Biochemistry; 1999 Feb; 38(8):2240-7. PubMed ID: 10029516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arrestin variants display differential binding characteristics for the phosphorylated N-formyl peptide receptor carboxyl terminus.
    Potter RM; Key TA; Gurevich VV; Sklar LA; Prossnitz ER
    J Biol Chem; 2002 Mar; 277(11):8970-8. PubMed ID: 11777932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional capabilities of an N-formyl peptide receptor-G(alpha)(i)(2) fusion protein: assemblies with G proteins and arrestins.
    Shi M; Bennett TA; Cimino DF; Maestas DC; Foutz TD; Gurevich VV; Sklar LA; Prossnitz ER
    Biochemistry; 2003 Jun; 42(24):7283-93. PubMed ID: 12809484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation and nuclear translocation of ERK1/2 by the formyl peptide receptor is regulated by G protein and is not dependent on beta-arrestin translocation or receptor endocytosis.
    Gripentrog JM; Miettinen HM
    Cell Signal; 2005 Oct; 17(10):1300-11. PubMed ID: 16038804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High constitutive activity of the human formyl peptide receptor.
    Wenzel-Seifert K; Hurt CM; Seifert R
    J Biol Chem; 1998 Sep; 273(37):24181-9. PubMed ID: 9727041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-formyl peptide receptor phosphorylation domains differentially regulate arrestin and agonist affinity.
    Key TA; Foutz TD; Gurevich VV; Sklar LA; Prossnitz ER
    J Biol Chem; 2003 Feb; 278(6):4041-7. PubMed ID: 12424254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-formyl peptide receptors cluster in an active raft-associated state prior to phosphorylation.
    Xue M; Vines CM; Buranda T; Cimino DF; Bennett TA; Prossnitz ER
    J Biol Chem; 2004 Oct; 279(43):45175-84. PubMed ID: 15302864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficient homologous desensitization of formyl peptide receptors stably expressed in undifferentiated HL-60 cells.
    Rane MJ; Prossnitz ER; Arthur JM; Ward RA; McLeish KR
    Biochem Pharmacol; 2000 Jul; 60(2):179-87. PubMed ID: 10825462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of F110 and C126 of the formyl peptide receptor interfere with G-protein coupling and chemotaxis.
    Jones BE; Miettinen HM; Jesaitis AJ; Mills JS
    J Periodontol; 2003 Apr; 74(4):475-84. PubMed ID: 12747452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of low affinity N-formyl peptide receptors to G protein. Characterization of a novel inactive receptor intermediate.
    Prossnitz ER; Schreiber RE; Bokoch GM; Ye RD
    J Biol Chem; 1995 May; 270(18):10686-94. PubMed ID: 7738006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential phosphorylation paradigms dictate desensitization and internalization of the N-formyl peptide receptor.
    Maestes DC; Potter RM; Prossnitz ER
    J Biol Chem; 1999 Oct; 274(42):29791-5. PubMed ID: 10514456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ligand binding site of the formyl peptide receptor maps in the transmembrane region.
    Miettinen HM; Mills JS; Gripentrog JM; Dratz EA; Granger BL; Jesaitis AJ
    J Immunol; 1997 Oct; 159(8):4045-54. PubMed ID: 9378994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of ligand-receptor dynamics to actin polymerization in RBL-2H3 cells transfected with the human formyl peptide receptor.
    Hall AL; Wilson BS; Pfeiffer JR; Oliver JM; Sklar LA
    J Leukoc Biol; 1997 Oct; 62(4):535-46. PubMed ID: 9335325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NH2-terminal region of C5aR but not that of FPR is critical for both protein transport and ligand binding.
    Mery L; Boulay F
    J Biol Chem; 1994 Feb; 269(5):3457-63. PubMed ID: 8106386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.